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Interleukin 4 (11-4) is an immunoregulatory cytokine which induces T-cell proliferation and differentiation into 
a Th, phenotype, and is of particular importance for the induction of IgE synthesis. In the present study, the 
capability of human peripheral blood eosinophils from allergic and non-allergic donors to produce 11-4 was 
examined. Using reverse transcribed polymerase chain reaction (RT-PCR), it was shown that highly purified 
eosinophils from allergic patients express mRNA for 11-4. Resting eosinophils also gave specific immuno- 
reactivity with anti-11-4 antibodies, consistent with translation of 11-4 mRNA. Light and electron microscopic 
immunocytochemistry revealed that 11-4 was prestored in the eosinophilic granules. These results were 
confirmed by 11-4 specific ELISA which showed that 11-4 production could be upregulated in the eosinophils 
and released from the eosinophils following stimulation with the calcium ionophore A23187. These data 
indicate that eosinophils may be an important source of 11-4 at sites of allergic inflammation. Thus, eosinophils 
may act as immunomodulatory cells enhancing the allergic response through formation of Th,-cells and 
inducing the isotype switching to IgE in human B-cells. 
Introduction 
Interleukin 4 is an important immunoregulatory 
cytokine with many biological activities and cellular 
targets. This cytokine has been shown to have a 
fundamental role in the pathogenesis of IgE- 
mediated hypersensitivity. It is well established that 
11-4 acts on T-cells inducing T-cell proliferation and 
differentiation into a Th, phenotype inducing isotype 
switching to IgE in human B-cells (1,2). Further- 
more, 11-4 induces the expression of the low affinity 
IgE receptor (FcERII) on human B-cells and mono- 
cytes (3,4). Additionally, 11-4 has been reported to be 
chemotactic for fibroblasts (5), and blood eosinophils 
from atopic dermatitis patients (6). Interleukin 4 
production is not restricted to T-cells (7), but also 
FceRI expressing bone marrow non-B-, non-T-cells 
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(8), lung mast cells (9) and, as recently shown, 
human peripheral blood basophils (10) have the 
capability of expressing 11-4. However, little is 
known about 11-4 expression in leukocytes such as 
eosinophils 
Eosinophils are one of the major effector cells 
in asthma and contribute to the pathogenesis by 
secretion of potent inflammatory mediators (11). 
Moreover, eosinophils are highly implicated in host 
defences against parasites (12). Recent studies have 
shown that human eosinophils can express various 
cytokines including transforming growth factor-a 
(TGF-a, granulocyte/macrophage colony-stimulating 
factor (GMCSF), 11-5, 11-8 and tumour necrosis 
factor (TNF) (13-18). 
This report shows that highly purified blood 
eosinophils from allergic patients express both 11-4 
mRNA and the protein. The subcellular localization 
of 11-4 is in the granules of the eosinophils. Finally, it 
is demonstrated that calcium ionophore increases 11-4 
expression and causes the eosinophils to release the 
cytokine. 
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Methods 
ISOLATION OF HUMAN EOSINOPHILS 
Eosinophils and neutrophils were purified from the 
peripheral blood of healthy volunteers (n=lO) or 
from allergic patients (n= 14) suffering from allergic 
asthma or allergic rhinoconjunctivitis as defined by 
clinical criteria, positive skin prick test and the 
presence of allergen-specific IgE in serum using 
negative selection with anti-CD16-coated magnetic 
microspheres as described (19). The purities of the 
eosinophil suspensions were 983% f 1.4% (n=24) as 
determined by Eosin stain and confirmed by differ- 
ential counts using May-Grunwald-Giemsa. Neutro- 
phils were the contaminating cells. Cell viabilities 
were >98%. 
RNA EXTRACTION AND cDNA SYNTHESIS 
Highly purified blood eosinophils (purity: 98.4% f 
l.O%, IZ= 13) were lysed in guanidinium thiocyanate 
and total RNA was extracted by the method of 
Chomecynski and Sacchi (20). Total RNA was 
reverse transcribed to cDNA using Moloney Murine 
Leukemia Virus and oligo dT primer (First Strand 
cDNA synthesis kit, Pharmacia, Uppsala, Sweden). 
For the polymerase chain reaction (PCR), 1~1 cDNA 
was used as template. 
POLYMERASE CHAIN REACTION AMPLIFICATION AND 
DETECTION OF PCR PRODUCTS 
Polymerase chain reactions were carried out in 
50~1 volumes containing 1~1 cDNA, 25 pmol of 
each primer, 0.3 mrvr each of dATP, dCTP, dGTP and 
dTTP, 1 unit Taq polymerase (Amplitaq, Perkin 
Elmer) and 5 ~1 10 x PCR buffer supplied with Taq 
polymerase. Primersequences for 11-4: senseprimer 
5’ ATGGGTCTCACCTCCCAACTGCT 3’ and anti- 
senseprimer 5’ TACTCTCTCTTTATAAGTTTCAC 
AAGC 3’ (Stratagena). The primers amplify a 456 bp 
PCR product. Amplifications were performed in 
automatic temperature cycler (OmniGene, Hybaid). 
Samples were overlaid with mineral oil and incubated 
for 5 min at 94°C 45 s at 58°C and 1.5 min at 72°C; 
then four cycles of 45 s at 94°C 45 s at 58°C and 
1.5 min at 72°C; and 40 cycles of 45 s at 94°C 45 s at 
58°C and 1.5 min at 72°C. The PCR products were 
electrophoresed through an ethidium-bromide stained 
2% agarose gel at 80 V for 30 min and the PCR 
products were visualized by UV radiation. 
IMMSJNOLOCALIZATION OF IL-4 IN EOSINOPHILS 
For immunocytochemistry, suspensions of eosino- 
phils were fixed in 4% paraformaldehyde. For light 
microscopy, 0.8 pm sections were obtained at - 80°C 
and for electron microscopy, 70-90 nm sections were 
obtained at about - 100°C. All cryo-ultramicrotomy 
sections were obtained from a Reichert FCS Ultracut 
S cryo-ultramicrotome. For immunolabelling, the 
sections were incubated with primary antibodies 
(anti-11-4 mAb 1: 1 OO- 1:400, Genzyme) either at room 
temperature for 1 h or overnight at 4°C after 
pre-incubation in phosphate-buffered saline (PBS) 
containing 0.05 M glycine and 1% BSA. For light 
microscopy, the sections were subsequently incu- 
bated with (1 h, room temperature) goat anti-mouse 
biotinylated F(ab)z (E433, 1:1200, Dako A/S, 
Glostrup, Denmark), and then incubated with 
alkaline phosphatase-conjugated avidin (D365, 1:50, 
Dako). Finally, the reactions were visualized with 
fast red and the cryosections subsequently counter- 
staining with Mayer. The preparation for electron 
microscopic immunolabelling was performed accord- 
ing to Tokuyasu (21) as modified by Griffiths (22). 
Briefly, following incubation with anti-114 mAb, the 
sections were subsequently incubated with colloidal 
gold coupled directly to the goat anti-mouse second- 
ary antibody (CAM 10 nm, l:lOO, BioCell). Finally, 
the grids were covered with methocel containing 0.3% 
uranyl acetate. The sections were studied in a Philips 
CM 100 electron microscope. Specificity of immuno- 
labelling was confirmed by (i) incubation with 
equivalent concentrations of an irrelevant mouse 
anti-human IgG, mab (X931, Dako) as a primary 
antibody; (ii) pre-adsorption of anti-11-4 with 11-4 
protein (Pharmingen, San Diego, U.S.A.) and (iii) 
incubation without the primary antibody, and with 
GAM alone. 
STIMULATION OF EOSINOPHILS 
Purified eosinophils were incubated under sterile 
conditions with either culture medium alone consist- 
ing of RPM1 1640 supplemented with 10% FCS, 
100 U ml - i penicillin and 100 pg ml - r streptomycin 
or with A23187 (lo- 7 M, Sigma). All incubations 
were performed in duplicate. 
ELISA FOR IL-4 
Interleukin 4 was measured by a double sandwich 
ELISA using monospecific, polyclonal rabbit anti- 
body (23) and a monoclonal antibody (Genzyme, 
Cambridge, MA, U.S.A.). To increase the measure- 
ment range, polyclonal and monoclonal 11-4 anti- 
bodies were mixed in the catching layer. Immuno- 
Maxisorp plates (NUNC) were coated overnight, 4°C 
with a 1:l mixture of polyclonal (1: 1000) and mono- 
clonal (5 pg ml - ‘) antibodies. Non-attached sites 
were blocked (2 h, 37°C) with 1% human serum 
albumin in PBS. Samples or standard (Genzyme) 




Plate I Qualitative analysis of 11-4 mRNA in purified eosinophils by RT-PCR. Lane 1: ldra marker; lane 2: 11-4 PCR 
prod1 .xt from purifiec 1 eosinophils; lane 3: positive control showing 11-4 PCR product from PMNC. 
diluted in RPM1 1640 with 10% FCS were added and 
incubated overnight. The assay was calibrated with 
an international standard preparation of human 11-4 
(National Institute for Biological Standards and 
Controls, Potters Bar, Hertfordshire, U.K.). For 
development, biotinylated rabbit antibody (1:2000) 
was used along with avidin-peroxidase (1:5000, 
Sigma, St. Louis, MO, U.S.A.). Development was 
carried out with 1,2-phenylendiamine dihydro- 
chloride and measured at 492 nm with a 6000-nm 
reference. The sensitivity of the ELISA was 
33pgml-‘. 
STATISTICAL ANALYSIS 
Data are expressed as mean It SE. Non parametric 
tests (Mann-Whitney and Wilcoxon) were used for 
comparison of means, a P value of 0.05 or less being 
considered to be significant. 
Results and Discussion 
In the first set of experiments, qualitative RT-PCR 
was used in order to determine whether specific 11-4 
mRNA sequences could be detected from highly 
purified (>97% pure) eosinophils obtained from 
allergic donors. The two primers specific for human 
11-4 used for the PCR reaction encompasses 
sequences from exon 1 to exon 4 of the mature 11-4 
mRNA and should produce a 456 bp PCR product if 
authentic human 11-4 cDNA is present. Total RNA 
from PMNC was used as a positive control. Lanes 2 
and 3 in Plate 1 demonstrate 11-4 amplification from 
purified eosinophils and PMNC, respectively. Nega- 
tive controls containing all the reagents except for the 
starting human eosinophil or peripheral mononu- 
clear cells (PMNC) cDNA templates were negative. 
Interleukin 4 mRNA was detected from unstimulated 
eosinophils in five of 13 allergic donors indicating a 
constitutively synthesis of 11-4 mRNA in some 
donors. To investigate whether formation of 11-4 
mRNA could be induced by eosinophils, cells from 
one of the ‘negative’ 11-4 mRNA donors were stimu- 
lated with calcium ionophore A231 87 (10 - 7 M) for 0, 
1, 3, 6, 12 and 24 h followed by RNA extraction and 
PCR amplification. These results revealed that 11-4 
mRNA was induced upon stimulation and could be 
detected after 3 and 6 h incubation with A23 187 (not 
shown). Prolonged stimulation did not produce any 
detectable mRNA transcript suggesting a rapid peak 
and turnover for 11-4 mRNA in human eosinophils. 
In parallel with the present findings, a previous study 
has shown that A23 187 can induce GM-CSF mRNA 
in purified eosinophils (15). 
To obtain evidence that 11-4 mRNA in the eosino- 
phils was translated into 11-4 protein, immunocyto- 
chemistry was performed on cryosections of purified 
unstimulated eosinophils from different donors using 
a anti-11-4 rnAb. Plate 2 illustrates the localization of 
11-4 using the light microscopy APAAP method. 
Extensive intracellular immunoreaction was found in 
many of the eosinophils examined. However, some of 
the cells in the sections were totally immunonegative 
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Plate 2 Immunohistochemical localization of 11-4 in Og5,um cryosections of eosinophils from an allergic donor. 
Unstimulated eosinophils showed strong intracellular immunoreaction exhibiting a granular pattern of staining (A and B). 
A proportion of the eosinophils were negative (arrowheads). Neg.1 shows pre-adsorbed control (anti-114 mAb was 
pre-adsorbed with pure 11-4) and Neg. 2 where an irrelevant isotype-matched mAb is the primary antibody were all negative 
(A: x 314, B: x 570, Neg.1 and Neg.2: x 143). 
indicating that a restricted proportion of the eosino- 
phils express 11-4 protein (Plate 2, A,B). This finding 
suggests the existence of 11-4 positive and 11-4 nega- 
tive eosinophils. Specificity of the staining was dem- 
onstrated by pre-adsorption of anti-11-4 with purified 
11-4 (Neg.1) or incubating with a irrelevant isotype- 
matched antibody substituting the anti-11-4 mAb 
(Neg.2). The subcellular localization of 11-4 in the 
eosinophils was then determined using immuno- 
electron microscopy with anti-11-4 mAb and goat 
anti-mouse-IgG conjugated goldparticles. As shown 
in Plate 3(A and B), a strong and specific immuno- 
labelling was found in the electron dense granules. 
Taken together, these results strongly suggest that 
human blood eosinophils prestore 11-4 protein in the 
granules. 
To examine the amounts of 11-4 in freshly isolated 
eosinophils from both non-allergic and allergic 
donors, a double sandwich ELISA which was cali- 
brated according to international standards was 
used. Table 1 shows that a significant difference in 
11-4 levels (WO.0001) was found between the two 
groups of donors. Interleukin4 in eosinophils from 
allergic donors was 1389 f 293 (mean & SE) pg 10 - 6 
cells. In contrast, only one non-allergic donor 
expressed 11-4 suggesting a possible regulation of the 
cytokine in allergic donors. Moreover, 11-4 could not 
be detected in purified neutrophils from any of the 
donors, suggesting that neutrophils from the two 
groups of donors do not have the capability of 
producing 11-4. The expression of 11-4 has previously 
been found in both mast cells and basophils (9,lO). In 
the first study showing 11-4 in basophils, mature 
human peripheral blood basophils from non-allergic 
donors were cultured with 11-3 followed by cross- 
linking of the high affinity IgER before 11-4 was 
detectable in the cell supernatants (10). These results 
have now been confirmed and extended by others 
(24), suggesting that human basophils might influ- 
ence the function of the adaptive immune system. 
Following the observation that 11-4 is synthesized 
and prestored in the eosinophils, it was formally 
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Plate 3 Subcellular localization of 11-4 in eosinophils by immunogold EM. (A) Eosinophils showed strong immunolabel- 
ling of 11-4 in the electron dense granules (G). Empty granules (EG) are not labelled in the matrix. Areas depleted for 
granules were negative, and no background labelling in the nucleus (N), nor of the plasma membrane @m) was observed. 
(B) Intense immunogold labelling of the granules illustrated at a higher magnification indicating that 11-4 is prestored in 
these organelles. (C) In controls, an irrelevant isotypespecific mAb is substituted for the anti-11-4 mAb. No specific 
immunolabelling is observed. All bars are 500 nm. 
tested whether 11-4 could be released from the cells, GMCSF, activate mature peripheral blood eosino- 
and whether the production of 11-4 protein could be phils in vitro (25). In addition, studies have shown 
regulated. Several cytokines, including 11-5, 11-3 and that incubation with calcium ionophore is followed 



















Fig. I Upregulation (a) and release (b) of II-4 in human 
blood eosinophils purified from allergic patients following 
calcium ionophore stimulation. Eosinophils from non- 
allergic donors did not respond on A 23187 stimulation (not 
shown). a: n=6, b: n=4, values are mean f SE. 
by upregulation and release of cytokine from 
eosinophils (14,17). The next sets of experiments were 
stimulated with calcium ionophore (A23187) for 3 h. 
As shown in Fig. 1, A23187 was capable of both 
regulating the expression of 11-4 and inducing release 
of the cytokine from eosinophils purified from aller- 
gic donors. This effect was, however, not evident in 
purified eosinophils from non-allergic donors (not 
shown). This provides the first evidence that human 
blood eosinophils are a significant source of this 
cytokine acting in the allergic inflammation. One 
could speculate that when 11-4 protein is detected 
within the eosinophil, this could be due to uptake of 
exogenous cytokines by pinocytosis or by an active 
and specific process. The fact that mRNA for 11-4 
could be demonstrated, and moreover, both B-4 
mRNA and protein could be induced by in vitro 
stimulation shows that 11-4 is in fact actively 
expressed and synthesized by the eosinophil. Bearing 
in mind the well-established fact that human blood 
eosinophils migrate into the tissues, e.g. in the 
bronchial submucosa (1 l), the present findings sug- 
gest that infiltrating eosinophils may act as immu- 
noregulatory cells in the initiating and particularly 
the propagation of the allergic inflammation. 
There are several indications that 11-4, originally 
identified as a B-cell differentiation and growth fac- 
tor, may be very active not only in lymphoid tissue 
but also in inflamed tissue. A majority of the 11-4 
which can be detected in the airways by immuno- 
histochemistry has been ascribed to mast cells (26). 
On the other hand, experiments employing 11-4 defi- 
cient or mast-cell-deficient mice have suggested that 
the T-cells rather than the mast cells are the import- 
ant source of the 11-4, which is required for the 
migration of eosinophils to the airways (27). This was 
confirmed by in situ hybridization techniques subse- 
quent to allergen challenge in asthmatic patients (28). 
Until now, eosinophils have not been considered 
as an important source of 11-4 in the airways. 
Even though the present results suggest 11-4 as an 
eosinophilic cytokine, the actual relevance of the 
cytokine and its possible autocrine or paracrine 
effects in the allergic cytokine networks remains to be 
determined. In this respect, the suggestion that 
basophils can provide non-cognate help for isotype 
switch and IgE synthesis through 11-4 secretion and 
surface expression of the CFD40-ligand is interesting 
(29). 
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